Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Founded
2014
Number of Employees
168
Website
http://www.zentalis.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)